Rutland Herald

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Times Argus

Dr. Rubinstein Offers Expanded Facial Rejuvenation Options in Montvale, NJ and Newburgh, NY as FDA Approves Restylane(R) Contour for Temple Hollowing

Double board-certified facial plastic surgeon expands Restylane Contour offerings at Rubinstein Plastic Surgery Center in Montvale, NJ and Laser & Cosmetic Surgery Specialists in Newburgh, NY ...
WFMZ-TV

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.